However,
Zurich scholarship: smi hesitating before:
Zurich (AWP) – The Swiss Stock Exchange was narrowly in the red on Monday morning. For example, investors being on the restraint in the start of a week in charge of business results and macroeconomic data. Consequently, In Switzerland. However, a dozen star values will unveil their financial performance in the first six months of the year in the coming days with in particular Nestlé, Roche and Givaudan.
“Crucial week in the American markets. Therefore, where Alphabet, Tesla, Intel and IBM will publish their results, as well as the Defense Giants Raytheon and Lockheed Martin,” summed up John Plassard, head of the investment strategy at the Cité Gestion bank, in a market comment.
In the euro zone. Meanwhile, the European Central Bank (ECB) is expected to maintain its unchanged guiding rates on Thursday after seven consecutive decreases, despite the threat of US President zurich scholarship: smi hesitating before Donald Trump to impose a heavy surcharge on imports from the European Union. The president of the ECB. Christine Lagarde, had warned in June that the central bank had arrived “at the end of a monetary policy cycle”.
For Jochen Stanzl, chief analyst of CMC Markets, the uncertainties linked to the trade war are not ready to disappear. “Even in the event of agreement between the European Union. the United States, it should hatch a framework agreement” whose details will still have to be negotiated “beyond the deadline of August 1, he added, fearing that” investors may expect a little too much from an agreement “with Washington.
On the Swiss Stock Exchange around 10:30 am, the SMI star index only fell 0.02% to 11,980.50 points, after having dropped by 0.38%. The SLI went up the slope and earned 0.13% at 1991.34 points and the SPI took 0.08% at 16,759.46 points.
A majority of zurich scholarship: smi hesitating before star values had come back to the green, led by Schindler (+2.0%), ABB (+1.8%) and Vat Group (+1.2%). Additionally, The electrical engineering giant saw its recommendation noted by Citigroup to purchase. against neutral previously, while the elevator manufacturer saw its own increased by Kepler Cheuvreux to “Hold”, from “Reduce”.
Julius Bär (+0.6%) also progressed. The fortune manager will publish its half -yearly results on Tuesday. analysts interviewed by AWP expect an acceleration of assets under management and new money influx.
The highest drops were recorded by Amrize (-1.2%), Richemont (-0.6%) and Roche (-0.5%), which has undergone several reverse on its development drugs.
On Friday. the American Medicines Agency (FDA) estimated that a clinical study on the Columvi anticancer did not provide enough evidence for approval in a specific combination. This Monday. the pharmaceutical group indicated that a phase III clinical study comparing Astegolimab treatment to a placebo, in addition to standard maintenance treatment zurich scholarship: smi hesitating before in people with chronic obstructive bronchopneumopathy (BPCO) moderate to very severe, has not reached its main objective.
The other two heavy goods vehicles Novartis (-0.1%) and Nestlé (-0.5%), which published its results on Thursday, also weighed on the star index.
On the enlarged market, Belimo (+5.7%) was strongly sought after, after a conclusive half -year performance and the confirmation of the prospects for the current year.
DKSH (+1.2%) bounced. The distribution service provider has announced the signing of an agreement for the acquisition of the activities of the. German Eppendorf in Thailand.
Al/IB
Zurich scholarship: smi hesitating before
Further reading: A strike on the Catholic Church of Gaza left two dead – Switzerland bows to Spain in the quarter -finals – 150 years ago: in Cavaione, the last mass naturalization in Switzerland – Switzerland has attracted a “new audience”, according to Dominique Blanc – Risk prevention: new paravalanches to protect the Baye and its inhabitants.